MARGARET G MCGLYNN Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
Get free email notifications about insider trading for MARGARET G MCGLYNN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARGARET G MCGLYNN. MARGARET G MCGLYNN is Director in AIR PRODUCTS & CHEMICALS INC /DE/ ($APD) and Pres.U.S.Human Health in MERCK SHARP & DOHME CORP. ($MRK) and President, GV & ID in MERCK SHARP & DOHME CORP. ($MRK) and President, Merck Vaccines in MERCK SHARP & DOHME CORP. ($MRK) and President, MV & ID in MERCK SHARP & DOHME CORP. ($MRK) and Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in NOVAVAX INC ($NVAX) and Director in AMICUS THERAPEUTICS INC ($FOLD).
MARGARET G MCGLYNN in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARGARET G MCGLYNN: Director
Holdings: 1,798 shares
Current Value: $156,138
Latest Transaction: May 04 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARGARET G MCGLYNN in VERTEX PHARMACEUTICALS INC / MA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APD, FOLD, MRK, NVAX, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 217.20 | 3,034 | 658,985 | 3,034 | |
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 921 | 0 | 1,798 | 877 to 1.8 K (+105.02 %) |
Aug 26 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 3,707 | 0 | 877 | 4.6 K to 877 (-80.87 %) |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 286.27 | 2,264 | 648,115 | 2,264 | |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 699 | 0 | 4,584 | 3.9 K to 4.6 K (+17.99 %) |
Nov 20 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Gift | G | 0.00 | 239 | 0 | 3,885 | 4.1 K to 3.9 K (-5.80 %) |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 72.14 | 20,000 | 1,442,800 | 0 | |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 190.00 | 20,000 | 3,800,000 | 4,124 | 24.1 K to 4.1 K (-82.90 %) |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 72.14 | 20,000 | 1,442,800 | 24,124 | 4.1 K to 24.1 K (+484.97 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 81.54 | 10,000 | 815,400 | 0 | |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 185.00 | 10,000 | 1,850,000 | 4,124 | 14.1 K to 4.1 K (-70.80 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
Aug 15 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 81.54 | 10,000 | 815,400 | 14,124 | 4.1 K to 14.1 K (+242.48 %) |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 1,801 | 0 | 3,989 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 168.04 | 6,659 | 1,118,978 | 6,659 | |
Jun 04 2019 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | D | 0.00 | 1,801 | 0 | 4,124 | 5.9 K to 4.1 K (-30.40 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 0.00 | 2,188 | 0 | 2,188 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | D | 0.00 | 2,188 | 0 | 5,925 | 8.1 K to 5.9 K (-26.97 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 1,801 | 0 | 8,113 | 6.3 K to 8.1 K (+28.53 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 0 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 59.55 | 10,000 | 595,500 | 10,000 | |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 165.00 | 10,000 | 1,650,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 160.00 | 10,000 | 1,600,000 | 6,217 | 16.2 K to 6.2 K (-61.66 %) |
Jan 24 2018 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 59.55 | 10,000 | 595,500 | 16,217 | 6.2 K to 16.2 K (+160.85 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 2,188 | 0 | 6,217 | 4 K to 6.2 K (+54.31 %) |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Grant | A | 0.01 | 2,941 | 29 | 4,029 | 1.1 K to 4 K (+270.31 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 0 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 130.15 | 12,500 | 1,626,875 | 1,088 | 13.6 K to 1.1 K (-91.99 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 12,500 | |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 138.98 | 100 | 13,898 | 1,088 | 1.2 K to 1.1 K (-8.42 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 138.22 | 2,700 | 373,194 | 1,188 | 3.9 K to 1.2 K (-69.44 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 137.26 | 6,500 | 892,190 | 3,888 | 10.4 K to 3.9 K (-62.57 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 136.49 | 3,200 | 436,768 | 10,388 | 13.6 K to 10.4 K (-23.55 %) |
Aug 05 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 53.85 | 7,500 | 403,875 | 0 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 5,000 | 286,350 | 25,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 127.53 | 9,020 | 1,150,321 | 1,088 | 10.1 K to 1.1 K (-89.24 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 126.78 | 3,480 | 441,194 | 10,108 | 13.6 K to 10.1 K (-25.61 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 53.85 | 7,500 | 403,875 | 13,588 | 6.1 K to 13.6 K (+123.19 %) |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 5,000 | 286,350 | 6,088 | 1.1 K to 6.1 K (+459.56 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 53.85 | 12,500 | 673,125 | 7,500 | |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 119.78 | 400 | 47,912 | 1,088 | 1.5 K to 1.1 K (-26.88 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 118.97 | 3,900 | 463,983 | 1,488 | 5.4 K to 1.5 K (-72.38 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 118.32 | 6,000 | 709,920 | 5,388 | 11.4 K to 5.4 K (-52.69 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 117.14 | 2,200 | 257,708 | 11,388 | 13.6 K to 11.4 K (-16.19 %) |
Apr 08 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 53.85 | 12,500 | 673,125 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Page: 1